ATE362538T1 - Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen - Google Patents

Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen

Info

Publication number
ATE362538T1
ATE362538T1 AT00938146T AT00938146T ATE362538T1 AT E362538 T1 ATE362538 T1 AT E362538T1 AT 00938146 T AT00938146 T AT 00938146T AT 00938146 T AT00938146 T AT 00938146T AT E362538 T1 ATE362538 T1 AT E362538T1
Authority
AT
Austria
Prior art keywords
genotype
viruses
infectious hepatitis
cloned genomes
sequence
Prior art date
Application number
AT00938146T
Other languages
English (en)
Inventor
Masayuki Yanagi
Jens Bukh
Suzanne Emerson
Robert Purcell
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE362538T1 publication Critical patent/ATE362538T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00938146T 1999-06-04 2000-06-02 Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen ATE362538T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13769399P 1999-06-04 1999-06-04

Publications (1)

Publication Number Publication Date
ATE362538T1 true ATE362538T1 (de) 2007-06-15

Family

ID=22478649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00938146T ATE362538T1 (de) 1999-06-04 2000-06-02 Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen

Country Status (5)

Country Link
EP (1) EP1185664B1 (de)
AT (1) ATE362538T1 (de)
AU (1) AU5322800A (de)
DE (1) DE60034884T2 (de)
WO (1) WO2000075338A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
US7115374B2 (en) 2002-10-16 2006-10-03 Gen-Probe Incorporated Compositions and methods for detecting West Nile virus
CN1833024B (zh) * 2003-05-26 2011-08-31 东丽株式会社 含有衍生自基因型2a丙肝病毒(HCV)基因组的核酸的核酸构建体和具有转移入其中的这样的核酸构建体的细胞
CA2539457C (en) 2003-09-19 2013-12-03 Tokyo Metropolitan Organization For Medical Research Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
US7790448B2 (en) 2003-09-19 2010-09-07 Tokyo Metropolitan Organization For Medical Research Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene
US7364854B2 (en) * 2004-01-23 2008-04-29 Biomerieux, Inc Nucleotide mixture for improved nucleic acid amplification performance
US7659103B2 (en) 2004-02-20 2010-02-09 Tokyo Metropolitan Organization For Medical Research Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle
DE602005026545D1 (de) 2004-08-24 2011-04-07 Tokyo Metropolitan Org Med Res Modifizierte genomische rna des menschlichen hepatitis-c-virus mit autonomer replikationskompetenz
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
JP2009051733A (ja) * 2005-12-13 2009-03-12 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
WO2011039639A2 (en) * 2009-10-02 2011-04-07 Hvidovre Hospital Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7
US9775894B2 (en) 2013-07-09 2017-10-03 University Of Washington Through Its Center For Commercialization Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
EP3670498A1 (de) * 2018-12-17 2020-06-24 Gottfried Wilhelm Leibniz Universität Hannover Verbindungen zur behandlung von hepaci-virusinfektionen und verfahren zur bestimmung der therapie von hepaci-virusinfektionen, insbesondere von hcv-infektionen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133402T2 (de) * 1990-04-04 2004-11-11 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Protease von hepatitis-c-virus
EP0532167A3 (en) * 1991-08-09 1993-03-31 Immuno Japan Inc. Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
AU1462300A (en) * 1998-11-05 2000-05-22 Board Of Trustees Of The Leland Stanford Junior University Human pan-hcv human monoclonal antibodies

Also Published As

Publication number Publication date
DE60034884D1 (de) 2007-06-28
WO2000075338A3 (en) 2001-11-01
DE60034884T2 (de) 2008-01-17
EP1185664B1 (de) 2007-05-16
AU5322800A (en) 2000-12-28
WO2000075338A2 (en) 2000-12-14
EP1185664A2 (de) 2002-03-13

Similar Documents

Publication Publication Date Title
ATE397070T1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
ATE366314T1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
DK0702085T4 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
ATE362538T1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
DK1114189T3 (da) Rekombinante Newcastle disease virus RNA ekspressionssystemer og vacciner
DE69841690D1 (de) Chimäre Impfstoffe gegen Flaviviren
DK0783321T3 (da) VR-2332 viral nucleotidsekvens og fremgangsmåder til anvendelse
ATE399210T1 (de) Knockout-mutante von vaccinia-virus und verwendung davon
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
DE69933121D1 (de) Methode, reagent und testsatz zur typisierung des genoms von papillomavirus
ATE461283T1 (de) Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
WO1999057284A3 (en) Attenuated influenza viruses
DK1383796T3 (da) Neurovirulent stamme af viruset West Nile og anvendelser heraf
WO2000075352A3 (en) Hcv/bvdv chimeric genomes and uses thereof
WO1997040166A3 (en) Simian-human hav having a chimeric 2c protein
WO2002061048A3 (en) In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
WO2003063679A3 (en) Hepatitis e virus clones and methods of their use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties